Australia's most trusted
source of pharma news
Friday, 26 April 2024
Posted 21 June 2022 AM
ViiV Healthcare came first in corporate reputation for pharmas in a survey of HIV patient groups, followed by Gilead and Janssen.
Created as a joint venture between GSK and Pfizer, ViiV focuses solely on treatments for HIV/AIDS. A PatientView survey of 168 patient groups around the world ranked the company the highest across nine indicators of corporate reputation.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.